Inactive Total Small Business Set-Aside (FAR 19.5)

The Regional Health Contracting Office - Central is issuing this Sources Sought Notice on behalf of San Antonio Military Medical Center (SAMMC), JBSA - Fort Sam Houston, Texas. Any responses to this S... The Regional Health Contracting Office - Central is issuing this Sources Sought Notice on behalf of San Antonio Military Medical Center (SAMMC), JBSA - Fort Sam Houston, Texas. Any responses to this Sources Sought Notice will be used for planning purposes only. Based on the responses to this notice, the requirement may be set-aside for small businesses, procured through full-and-open competition, or result in a sole-source contract. The proposed North American Industry Classification System (NAICS) Code is 325412 with a corresponding size standard of 1,250 employees. This notice is not a solicitation of offers, nor is it a notice to proceed. SAMMC has a requirement for Naloxone and compounded pharmaceuticals. The anticipated delivery date is 1 Jan 2022. Naloxone and compounded pharmaceuticals must meet the below salient characteristics: Naloxone 1mg/mL 2mL Oral Syringe Will contain a solution of Naloxone 1mg/ml packaged in 2mL oral syringe Will be packaged in an oral syringe with a tamper evident cap and without a luer lock tip Will be labeled for oral use only Must have a Beyond Use Date of no less than 30 days Ketamine 10mg/mL in Normal Saline 5mL in 10mL OR Syringe Will contain ketamine 10mg/mL mixed with Normal Saline 5mL packaged in a 10mL OR syringe Will have a label affixed to each syringe specifying the contents Must have a Beyond Use Date of no less than 30 days Ketamine 10mg/mL in Normal Saline 10mL in 10mL OR Syringe Will contain ketamine 10mg/mL mixed with Normal Saline 10mL packaged in a 10mL OR syringe Will have a label affixed to each syringe specifying the contents Must have a Beyond Use Date of no less than 30 days Norepinephrine 4mg in D5W 250mL bag Will contain norepinephrine 4mg added to 250mL bag of dextrose 5% in water Will have a label affixed to each bag specifying the contents Must have a Beyond Use Date of no less than 30 days Norepinephrine 8mg in D5W 250mL bag Will contain norepinephrine 8mg added to 250mL bag of dextrose 5% in water Will have a label affixed to each bag specifying the contents Must have a Beyond Use Date of no less than 30 days If your organization has the potential capacity to provide the Naloxone and compounded pharmaceuticals above, please provide the following information: 1) Organization name, address, e-mail address, Web site address, telephone number, and size (small versus large business, and any other socio-economic categories) and type of ownership for the organization; 2) Tailored capability statements addressing the particulars of this effort, with appropriate documentation supporting claims of organizational capability, to include proof of authorization to provide supplies and analyzer as well as maintenance and repair services on above-listed equipment. THERE IS NO SOLICITATION AT THIS TIME. This request for capability information does not constitute a request for proposals; submission of any information in response to this notice is purely voluntary; the Government assumes no financial responsibility for any costs incurred. Contractors responding to this sources sought notice are advised their response does not ensure participation in future solicitations or contract awards. The Government will not reimburse any company or individual for any expense associated with preparation or participation in this research. Interested parties should e-mail responses to cathy.l.harris2.civ@mail.mil by the date identified below. Submit response no later than 10 Dec 2021 at 1000 CST.